Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.6B | $4.1B | $4.4B | $4.5B | $4.5B | |
Revenue Growth (YoY) | 5.42% | 13.78% | 5.83% | 4.13% | -1.27% | |
Cost of Revenues | $2.2B | $2.5B | $2.7B | $2.9B | $2.8B | |
Gross Profit | $1.4B | $1.6B | $1.7B | $1.6B | $1.7B | |
Gross Profit Margin | 38.76% | 38.73% | 38.75% | 36.34% | 38.56% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $773.1M | $868.9M | $907.8M | $901.9M | $907.7M | |
Other Inc / (Exp) | -- | -- | $36.8M | $21.2M | $17.6M | |
Operating Expenses | $773.1M | $868.9M | $907.8M | $901.9M | $907.7M | |
Operating Income | $629.4M | $725.6M | $780.4M | $746.8M | $819.7M | |
Net Interest Expenses | $146.8M | $170.5M | $191.5M | $195.1M | $184.8M | |
EBT. Incl. Unusual Items | $482.6M | $555.1M | $625.7M | $572.8M | $652.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $81.9M | $63.8M | $115.2M | $120.6M | $133.3M | |
Net Income to Company | $400.7M | $491.3M | $510.5M | $452.3M | $519.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $400.7M | $491.3M | $510.5M | $452.3M | $519.1M | |
Basic EPS (Cont. Ops) | $9.83 | $12.61 | $13.72 | $12.66 | $14.80 | |
Diluted EPS (Cont. Ops) | $9.56 | $12.39 | $13.54 | $12.53 | $14.66 | |
Weighted Average Basic Share | $40.8M | $39M | $37.2M | $35.7M | $35.1M | |
Weighted Average Diluted Share | $41.9M | $39.6M | $37.7M | $36.1M | $35.4M | |
EBITDA | $693.4M | $792.3M | $890.4M | $851.3M | $929.6M | |
EBIT | $633.5M | $727.3M | $817.5M | $771.1M | $848.9M | |
Revenue (Reported) | $3.6B | $4.1B | $4.4B | $4.5B | $4.5B | |
Operating Income (Reported) | $629.4M | $725.6M | $780.4M | $746.8M | $819.7M | |
Operating Income (Adjusted) | $633.5M | $727.3M | $817.5M | $771.1M | $848.9M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $967.7M | $998M | $1.1B | $1B | $1.1B | |
Revenue Growth (YoY) | 17.9% | 3.13% | 7.08% | -3.86% | 5.14% | |
Cost of Revenues | $605.7M | $612.8M | $686.7M | $629.2M | $656.4M | |
Gross Profit | $362M | $385.2M | $381.9M | $398.2M | $423.7M | |
Gross Profit Margin | 37.41% | 38.6% | 35.73% | 38.76% | 39.23% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $199.8M | $204.9M | $205.4M | $208.7M | $224.9M | |
Other Inc / (Exp) | -- | -- | -- | $28.2M | $26.2M | |
Operating Expenses | $199.8M | $204.9M | $205.4M | $208.7M | $224.9M | |
Operating Income | $162.2M | $180.3M | $176.5M | $189.4M | $198.8M | |
Net Interest Expenses | $38.4M | $45.5M | $44.6M | $42.1M | $40.4M | |
EBT. Incl. Unusual Items | $123.8M | $134.8M | $131.8M | $175.6M | $184.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24.6M | $14.4M | $31.3M | $27.9M | $37.7M | |
Net Income to Company | $99.1M | $120.4M | $100.5M | $147.7M | $146.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $99.1M | $120.4M | $100.5M | $147.7M | $146.9M | |
Basic EPS (Cont. Ops) | $2.53 | $3.29 | $2.82 | $4.22 | $4.22 | |
Diluted EPS (Cont. Ops) | $2.49 | $3.24 | $2.79 | $4.18 | $4.19 | |
Weighted Average Basic Share | $39.2M | $36.6M | $35.7M | $35M | $34.8M | |
Weighted Average Diluted Share | $39.8M | $37.1M | $36.1M | $35.4M | $35M | |
EBITDA | $177.7M | $196.9M | $196.2M | $238.6M | $250.1M | |
EBIT | $162.4M | $180.3M | $177.3M | $220.4M | $229.3M | |
Revenue (Reported) | $967.7M | $998M | $1.1B | $1B | $1.1B | |
Operating Income (Reported) | $162.2M | $180.3M | $176.5M | $189.4M | $198.8M | |
Operating Income (Adjusted) | $162.4M | $180.3M | $177.3M | $220.4M | $229.3M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $3.9B | $4.4B | $4.5B | $4.5B | $4.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.4B | $2.7B | $2.8B | $2.8B | $2.8B | |
Gross Profit | $1.5B | $1.7B | $1.6B | $1.7B | $1.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $821M | $915.5M | $901.1M | $910.1M | $959M | |
Other Inc / (Exp) | -- | $2.5M | $34.3M | $13.1M | $23.2M | |
Operating Expenses | $821M | $915.5M | $901.1M | $910.1M | $959M | |
Operating Income | $685.5M | $801.8M | $741.8M | $790.1M | $862.7M | |
Net Interest Expenses | $162.7M | $185.2M | $196.8M | $187.7M | $179.1M | |
EBT. Incl. Unusual Items | $522.8M | $619.1M | $579.2M | $636.7M | $706.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $54.1M | $112.4M | $129.6M | $116.6M | $134.7M | |
Net Income to Company | $468.7M | $506.7M | $449.6M | $520.1M | $572M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $468.7M | $506.7M | $449.6M | $520.1M | $572M | |
Basic EPS (Cont. Ops) | $12.03 | $13.29 | $12.48 | $14.76 | $16.43 | |
Diluted EPS (Cont. Ops) | $11.67 | $13.15 | $12.36 | $14.62 | $16.27 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $751.8M | $875.4M | $856.1M | $913.3M | $988.8M | |
EBIT | $688.8M | $804.3M | $777.4M | $834.1M | $902.2M | |
Revenue (Reported) | $3.9B | $4.4B | $4.5B | $4.5B | $4.7B | |
Operating Income (Reported) | $685.5M | $801.8M | $741.8M | $790.1M | $862.7M | |
Operating Income (Adjusted) | $688.8M | $804.3M | $777.4M | $834.1M | $902.2M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $2.8B | $3B | $3.1B | $3.1B | $3.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.7B | $1.8B | $2B | $1.9B | $2B | |
Gross Profit | $1.1B | $1.2B | $1.1B | $1.2B | $1.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $577.6M | $624.3M | $617.6M | $625.9M | $677.1M | |
Other Inc / (Exp) | -- | $2.5M | -- | $13.1M | $18.7M | |
Operating Expenses | $577.6M | $624.3M | $617.6M | $625.9M | $677.1M | |
Operating Income | $481.6M | $557.7M | $519.1M | $562.5M | $605.5M | |
Net Interest Expenses | $116M | $130.7M | $136.1M | $128.6M | $123M | |
EBT. Incl. Unusual Items | $365.6M | $429.5M | $383M | $446.9M | $501.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $26.2M | $74.8M | $89.1M | $85.1M | $86.5M | |
Net Income to Company | $339.4M | $354.8M | $294M | $361.8M | $414.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $339.4M | $354.8M | $294M | $361.8M | $414.7M | |
Basic EPS (Cont. Ops) | $8.71 | $9.43 | $8.20 | $10.29 | $11.91 | |
Diluted EPS (Cont. Ops) | $8.55 | $9.30 | $8.11 | $10.19 | $11.80 | |
Weighted Average Basic Share | $117M | $112.9M | $107.6M | $105.6M | $104.5M | |
Weighted Average Diluted Share | $119.2M | $114.5M | $108.8M | $106.6M | $105.4M | |
EBITDA | $527.5M | $610.6M | $576.2M | $638.2M | $697.5M | |
EBIT | $483.4M | $560.4M | $520.2M | $583.2M | $636.5M | |
Revenue (Reported) | $2.8B | $3B | $3.1B | $3.1B | $3.3B | |
Operating Income (Reported) | $481.6M | $557.7M | $519.1M | $562.5M | $605.5M | |
Operating Income (Adjusted) | $483.4M | $560.4M | $520.2M | $583.2M | $636.5M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $190.6M | $168.8M | $148.2M | $60.4M | $114.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $210.3M | $244.6M | $255.3M | $257.5M | $282.8M | |
Inventory | $53M | $66.7M | $68.3M | $81.6M | $83M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $19.1M | $24.2M | $27.2M | $37.3M | $30.2M | |
Total Current Assets | $787.6M | $869.4M | $860.5M | $790.7M | $817.3M | |
Property Plant And Equipment | $471.7M | $525.6M | $534.8M | $521.4M | $511.7M | |
Long-Term Investments | -- | $40M | $125.8M | $125.8M | $143.6M | |
Goodwill | $15.1M | $15.1M | $15M | $11.8M | $11.7M | |
Other Intangibles | $73.1M | $81.3M | $95.6M | $108.4M | $134.1M | |
Other Long-Term Assets | $24.5M | $33.9M | $38M | $42.2M | $42.9M | |
Total Assets | $1.4B | $1.6B | $1.7B | $1.6B | $1.7B | |
Accounts Payable | $111.1M | $94.5M | $91.5M | $89.7M | $106.3M | |
Accrued Expenses | $94.1M | $111.5M | $140.6M | $127.4M | $158.3M | |
Current Portion Of Long-Term Debt | $43.4M | $2.9M | $55.6M | $54.8M | $56.4M | |
Current Portion Of Capital Lease Obligations | $33.3M | $35.9M | $37.2M | $34.9M | $39.3M | |
Other Current Liabilities | $101.9M | $141.2M | $173.7M | $157.9M | $104.2M | |
Total Current Liabilities | $453.8M | $470.8M | $590.7M | $536.6M | $547.4M | |
Long-Term Debt | $4.1B | $4.1B | $4.9B | $5B | $4.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.8B | $4.9B | $5.9B | $5.8B | $5.7B | |
Common Stock | $389K | $389K | $361K | $354K | $347K | |
Other Common Equity Adj | -$3.7M | -$2.4M | -$2.8M | -$4.7M | -$3.9M | |
Common Equity | -$3.4B | -$3.3B | -$4.2B | -$4.2B | -$4.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$3.4B | -$3.3B | -$4.2B | -$4.2B | -$4.1B | |
Total Liabilities and Equity | $1.4B | $1.6B | $1.7B | $1.6B | $1.7B | |
Cash and Short Terms | $190.6M | $168.8M | $148.2M | $60.4M | $114.1M | |
Total Debt | $4.1B | $4.1B | $5B | $5B | $5B |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $330.7M | $295.4M | $114.8M | $80.9M | $189.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $229.4M | $238.9M | $242.8M | $250M | $278.7M | |
Inventory | $65.5M | $64.6M | $72.6M | $69.7M | $69.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $26.3M | $34.1M | $30.5M | $41.3M | $38.7M | |
Total Current Assets | $956.5M | $1B | $826.4M | $795.6M | $872.3M | |
Property Plant And Equipment | $491.9M | $511.5M | $529M | $500.3M | $508.4M | |
Long-Term Investments | -- | $82.5M | $125.8M | $139.1M | $162.4M | |
Goodwill | $15.1M | $15M | $16.2M | $11.7M | $11.6M | |
Other Intangibles | $78.6M | $91.4M | $105.5M | $125.2M | $151.9M | |
Other Long-Term Assets | $72.8M | $36.3M | $41.3M | $41.6M | $47.2M | |
Total Assets | $1.6B | $1.8B | $1.6B | $1.6B | $1.8B | |
Accounts Payable | $88.2M | $111.8M | $91.3M | $101.1M | $97.8M | |
Accrued Expenses | $126.7M | $151.1M | $144.9M | $146.8M | $176.5M | |
Current Portion Of Long-Term Debt | $42M | $54.8M | $55.8M | $55.8M | $4.9M | |
Current Portion Of Capital Lease Obligations | $38.2M | $37.1M | $40.8M | $38.6M | $40.8M | |
Other Current Liabilities | $138.3M | $178.5M | $173.3M | $147.3M | $109.2M | |
Total Current Liabilities | $488.5M | $596.4M | $578.7M | $562.9M | $510.5M | |
Long-Term Debt | $4B | $5B | $5.1B | $4.9B | $5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.8B | $5.9B | $6B | $5.8B | $5.8B | |
Common Stock | $394K | $366K | $354K | $349K | $345K | |
Other Common Equity Adj | -$3.4M | -$2.4M | -$3.8M | -$5.1M | -$4.9M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$3.2B | -$4.1B | -$4.3B | -$4.1B | -$4B | |
Total Liabilities and Equity | $1.6B | $1.8B | $1.6B | $1.6B | $1.8B | |
Cash and Short Terms | $330.7M | $295.4M | $114.8M | $80.9M | $189.1M | |
Total Debt | $4.1B | $5.1B | $5.2B | $5B | $5B |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $400.7M | $491.3M | $510.5M | $452.3M | $519.1M | |
Depreciation & Amoritzation | $59.9M | $65M | $72.9M | $80.3M | $80.6M | |
Stock-Based Compensation | $20.3M | $24.2M | $28.7M | $28.7M | $37.5M | |
Change in Accounts Receivable | -$20.9M | -$33.3M | -$8.1M | -$6.3M | -$26.5M | |
Change in Inventories | -$6.7M | -$25M | -$9.4M | -$17.1M | $160K | |
Cash From Operations | $497M | $592.8M | $654.2M | $475.3M | $590.9M | |
Capital Expenditures | $85.6M | $88.8M | $94.2M | $87.2M | $105.4M | |
Cash Acquisitions | -$3.4M | -- | -- | -$6.8M | -- | |
Cash From Investing | -$27.9M | -$128.9M | -$142.7M | -$53.7M | -$106.9M | |
Dividends Paid (Ex Special Dividend) | -$105.7M | -$121.9M | -$139.4M | -$157.5M | -$169.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $675M | $158M | $1.9B | $120M | $14.9M | |
Long-Term Debt Repaid | -$92.1M | -$202.1M | -$910.2M | -$175.7M | -$55.7M | |
Repurchase of Common Stock | -$699M | -$304.6M | -$1.3B | -$293.7M | -$269M | |
Other Financing Activities | -$14M | -$6.8M | -$22M | -$12.3M | -$5.4M | |
Cash From Financing | -$222.8M | -$446.4M | -$522.8M | -$515.9M | -$476.4M | |
Beginning Cash (CF) | $25.4M | $190.6M | $502.1M | $490.5M | $395.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $246.3M | $17.5M | -$11.4M | -$94.3M | $7.6M | |
Ending Cash (CF) | $190.6M | $168.8M | $490.5M | $395.2M | $403.1M | |
Levered Free Cash Flow | $411.4M | $504M | $560M | $388.1M | $485.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $151.9M | $155.7M | $158.3M | $157.3M | -- | |
Depreciation & Amoritzation | $20.9M | $22.7M | $24.2M | $25.6M | -- | |
Stock-Based Compensation | $9.3M | $9.2M | $7.1M | $11M | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $222.4M | $169.6M | $145.2M | $168.7M | -- | |
Capital Expenditures | $37.6M | $43.5M | $36.7M | $46.1M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$37.9M | -$52.4M | $5M | -$46.9M | -- | |
Dividends Paid (Ex Special Dividend) | -$60.8M | -$68.2M | -$77.8M | -$84.2M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$11.2M | -$14M | -$134.2M | -$14.4M | -- | |
Repurchase of Common Stock | -$225M | -$216.2M | -$1K | -$58.2M | -- | |
Other Financing Activities | -$219K | -$3K | -$1.6M | -$170K | -- | |
Cash From Financing | -$292.8M | -$294.7M | -$211.7M | -$139.2M | -- | |
Beginning Cash (CF) | $609.9M | $668.3M | $457.1M | $419.8M | -- | |
Foreign Exchange Rate Adjustment | $518K | -$374K | -$352K | $644K | -- | |
Additions / Reductions | -$108.3M | -$177.5M | -$61.5M | -$17.3M | -- | |
Ending Cash (CF) | $168.8M | $490.5M | $395.2M | $403.1M | -- | |
Levered Free Cash Flow | $184.8M | $126.1M | $108.4M | $122.6M | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $468.7M | $506.7M | $449.6M | $520.1M | $572M | |
Depreciation & Amoritzation | $63.1M | $71.1M | $78.7M | $79.2M | $86.6M | |
Stock-Based Compensation | $21.9M | $28.8M | $30.8M | $33.6M | $42.5M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $542.8M | $707M | $499.8M | $567.3M | $615.6M | |
Capital Expenditures | $94.1M | $88.3M | $94M | $96M | $116.9M | |
Cash Acquisitions | -- | -- | -$6.8M | -- | -- | |
Cash From Investing | -$115.8M | -$128.2M | -$111.1M | -$55M | -$118.8M | |
Dividends Paid (Ex Special Dividend) | -$113.2M | -$132.1M | -$147.9M | -$163.4M | -$190.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$191.1M | -$907.4M | -$55.5M | -$175.6M | -$30.3M | |
Repurchase of Common Stock | -$673.4M | -$1.3B | -$510M | -$210.8M | -$273.2M | |
Other Financing Activities | -$14.8M | -$22.2M | -$10.7M | -$6.9M | -$10.9M | |
Cash From Financing | -$130.1M | -$521M | -$598.9M | -$548.9M | -$452.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $296.9M | $57.8M | -$210.3M | -$36.6M | $44.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $448.7M | $618.7M | $405.7M | $471.3M | $498.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $491.3M | $510.5M | $452.3M | $519.1M | $414.7M | |
Depreciation & Amoritzation | $65M | $72.9M | $80.3M | $80.6M | $61M | |
Stock-Based Compensation | $24.2M | $28.7M | $28.7M | $37.5M | $31.5M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $592.8M | $654.2M | $475.3M | $590.9M | $446.9M | |
Capital Expenditures | $88.8M | $94.2M | $87.2M | $105.4M | $70.8M | |
Cash Acquisitions | -- | -- | -$6.8M | -- | -- | |
Cash From Investing | -$128.9M | -$142.7M | -$53.7M | -$106.9M | -$71.9M | |
Dividends Paid (Ex Special Dividend) | -$121.9M | -$139.4M | -$157.5M | -$169.8M | -$106M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $158M | $1.9B | $120M | -- | -- | |
Long-Term Debt Repaid | -$202.1M | -$910.2M | -$175.7M | -$55.7M | -$15.9M | |
Repurchase of Common Stock | -$304.6M | -$1.3B | -$293.7M | -$269M | -$215M | |
Other Financing Activities | -$6.8M | -$22M | -$12.3M | -$5.4M | -$10.7M | |
Cash From Financing | -$446.4M | -$522.8M | -$515.9M | -$476.4M | -$313M | |
Beginning Cash (CF) | $2.1B | $2.4B | $1.9B | $1.7B | $1.4B | |
Foreign Exchange Rate Adjustment | $761K | -$316K | -$963K | $340K | -$589K | |
Additions / Reductions | $17.5M | -$11.4M | -$94.3M | $7.6M | $62M | |
Ending Cash (CF) | $1.8B | $2.4B | $1.8B | $1.7B | $1.5B | |
Levered Free Cash Flow | $504M | $560M | $388.1M | $485.5M | $376.1M |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.